Jonathan A Fallowfield
Overview
Explore the profile of Jonathan A Fallowfield including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
59
Citations
2594
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Fairfield C, Drake T, Pius R, Bretherick A, Campbell A, Clark D, et al.
Hepatol Commun
. 2021 Sep;
6(2):297-308.
PMID: 34535985
Genome-wide association studies (GWAS) have identified several risk loci for nonalcoholic fatty liver disease (NAFLD). Previous studies have largely relied on small sample sizes and have assessed quantitative traits. We...
22.
Palaniyappan N, Fallowfield J
Aliment Pharmacol Ther
. 2021 Jul;
54(3):345-346.
PMID: 34236093
No abstract available.
23.
Kennedy O, Fallowfield J, Poole R, Hayes P, Parkes J, Roderick P
BMC Public Health
. 2021 Jun;
21(1):970.
PMID: 34154561
Background: Chronic liver disease (CLD) is a growing cause of morbidity and mortality worldwide, particularly in low to middle-income countries with high disease burden and limited treatment availability. Coffee consumption...
24.
Sethi P, Thavanesan N, Welsh F, Connell J, Pickles E, Kelly M, et al.
BJR Case Rep
. 2021 Jun;
7(3):20200172.
PMID: 34131498
It is not uncommon for clinicians to encounter varying degrees of hepatic steatosis in patients undergoing resection for colorectal liver metastases (CRLM). Magnetic resonance imaging is currently the preferred investigation...
25.
Astbury S, Grove J, Dorward D, Guha I, Fallowfield J, Kendall T
J Pathol Clin Res
. 2021 Jun;
7(5):471-481.
PMID: 34076968
Biopsy remains the gold-standard measure for staging liver disease, both to inform prognosis and to assess the response to a given treatment. Semiquantitative scores such as the Ishak fibrosis score...
26.
Wang J, Hou Z, Liu J, Gu Y, Wu Y, Chen Z, et al.
J Hepatol
. 2021 Apr;
75(2):439-441.
PMID: 33905793
Background & Aims: The development of COVID-19 vaccines has progressed with encouraging safety and efficacy data. Concerns have been raised about SARS-CoV-2 vaccine responses in the large population of patients...
27.
Dennis A, Kelly M, Fernandes C, Mouchti S, Fallowfield J, Hirschfield G, et al.
Front Endocrinol (Lausanne)
. 2021 Feb;
11:575843.
PMID: 33584535
Introduction: Late stage clinical trials in non-alcoholic steatohepatitis (NASH) are currently required by the FDA to use liver biopsy as a primary endpoint. The well-reported limitations with biopsy, such as...
28.
Fallowfield J, Ramachandran P
Nat Nanotechnol
. 2021 Jan;
16(4):365-366.
PMID: 33495619
No abstract available.
29.
Mole D, Fallowfield J, Sherif A, Kendall T, Semple S, Kelly M, et al.
PLoS One
. 2020 Dec;
15(12):e0238568.
PMID: 33264327
The risk of poor post-operative outcome and the benefits of surgical resection as a curative therapy require careful assessment by the clinical care team for patients with primary and secondary...
30.
Poole R, Ewings S, Parkes J, Fallowfield J, Roderick P
BMJ Nutr Prev Health
. 2020 Nov;
2(1):11-19.
PMID: 33235952
Background: Associations of coffee consumption with multiple health outcomes have been researched extensively. Coffee consumption, usually reported in cups a day, is a heterogeneous measure due to numerous preparation methods...